_id

690f3929ccc777a4e85d18b5

Ticker

BTAI

Name

BioXcel Therapeutics Inc

Exchange

NASDAQ

Address

555 Long Wharf Drive, New Haven, CT, United States, 06511

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.bioxceltherapeutics.com

Description

BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It also develops its neuroscience candidate, BXCL501, which is an investigational, proprietary, orally dissolving film formulation of dexmedetomidine in Phase 3 trial for the treatment of agitation associated with bipolar disorders, schizophrenia, and Alzheimer's disease, as well as opioid use disorder, alcohol use disorder with comorbid post-traumatic stress disorder, and acute stress disorder; and its immune-oncology candidate, BXCL701, which is an investigational oral innate immune activator that has completed Phase 1b/2a trial for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors. In addition, the company engages in the development of BXCL502 for the treatment of stress-related neuropsychiatric symptoms in dementia and other stress-related disorders; BXCL503, a drug candidate to target apathy in dementia; and BXCL504, which has the potential to address apathy and aggression in dementia. The company has collaborations with Columbia University, Yale University Medical School, and University of North Carolina for the development of BXCL501. BioXcel Therapeutics, Inc. was incorporated in 2017 and is headquartered in New Haven, Connecticut.

Last Close

2.07

Volume

652832

Current Price

2.01

Change

-2.898550724637684

Last Updated

2025-11-28T13:11:42.963Z

Image

data:image/webp;base64,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

Ipo Date

2018-03-08T00:00:00.000Z

Market Cap

45488540

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.813

Sentiment Sources

1

Rating

3.6667

Target Price

16.75

Strong Buy

1

Buy

1

Hold

0

Sell

1

Strong Sell

0

Current Quarter

2025-09-30

Revenue

98000

Cost Of Revenue

86000

Gross Profit

12000

Operating Expenses

13940000

Operating Income

-13928000

Interest Expense

4373000

Pretax Income

-30911000

Net Income

-30911000

Eps

-2.1774443505212737

Dividends Per Share

-

Shares Outstanding

21869491

Income Tax Expense

-

EBITDA

-26463000

Operating Margin

-14212.244897959185

Total Other Income Expense Net

-16983000

Cash

37320000

Short Term Investments

-

Receivables

0

Inventories

459000

Total Current Assets

44403000

Property Plant Equipment

389000

Total Assets

44792000

Payables

16276000

Short Term Debt

16984000

Long Term Debt

92302000

Total Liabilities

133711000

Equity

-88919000

Depreciation

75000

Change In Working Capital

-1596000

Cash From Operations

-18787000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

37532000

Net Change In Cash

18745000

PE

-

PB

-0.32089834568539904

ROE

34.76309900021368

ROA

-69.01009108769424

FCF

-18787000

Fcf Percent

-191.70408163265307

Piotroski FScore

1

Health Score

31

Deep Value Investing Score

2

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

6.3

Garp Investing Score

2.5

Growth Investing Score

2.5

Momentum Investing Score

4.5

Net Net Investing Score

1.5

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

98000

Quarters > 0 > income Statement > cost Of Revenue

86000

Quarters > 0 > income Statement > gross Profit

12000

Quarters > 0 > income Statement > operating Expenses

13940000

Quarters > 0 > income Statement > operating Income

-13928000

Quarters > 0 > income Statement > interest Expense

4373000

Quarters > 0 > income Statement > pretax Income

-30911000

Quarters > 0 > income Statement > net Income

-30911000

Quarters > 0 > income Statement > eps

-2.1774443505212737

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

14196000

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-26463000

Quarters > 0 > income Statement > operating Margin

-14212.244897959185

Quarters > 0 > income Statement > total Other Income Expense Net

-16983000

Quarters > 0 > balance Sheet > cash

37320000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

0

Quarters > 0 > balance Sheet > inventories

459000

Quarters > 0 > balance Sheet > total Current Assets

44403000

Quarters > 0 > balance Sheet > property Plant Equipment

389000

Quarters > 0 > balance Sheet > total Assets

44792000

Quarters > 0 > balance Sheet > payables

16276000

Quarters > 0 > balance Sheet > short Term Debt

16984000

Quarters > 0 > balance Sheet > long Term Debt

92302000

Quarters > 0 > balance Sheet > total Liabilities

133711000

Quarters > 0 > balance Sheet > equity

-88919000

Quarters > 0 > cash Flow > net Income

-30911000

Quarters > 0 > cash Flow > depreciation

75000

Quarters > 0 > cash Flow > change In Working Capital

-1596000

Quarters > 0 > cash Flow > cash From Operations

-18787000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

37532000

Quarters > 0 > cash Flow > net Change In Cash

18745000

Quarters > 0 > ratios > PE

-2.1774443505212737

Quarters > 0 > ratios > PB

-0.32089834568539904

Quarters > 0 > ratios > ROE

34.76309900021368

Quarters > 0 > ratios > ROA

-69.01009108769424

Quarters > 0 > ratios > FCF

-18787000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-191.70408163265307

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

120000

Quarters > 1 > income Statement > cost Of Revenue

107000

Quarters > 1 > income Statement > gross Profit

13000

Quarters > 1 > income Statement > operating Expenses

15865000

Quarters > 1 > income Statement > operating Income

-15852000

Quarters > 1 > income Statement > interest Expense

4222000

Quarters > 1 > income Statement > pretax Income

-19187000

Quarters > 1 > income Statement > net Income

-19187000

Quarters > 1 > income Statement > eps

-2.4463853117429557

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

7843000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-14890000

Quarters > 1 > income Statement > operating Margin

-13210

Quarters > 1 > income Statement > total Other Income Expense Net

-3335000

Quarters > 1 > balance Sheet > cash

17435000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

17000

Quarters > 1 > balance Sheet > inventories

506000

Quarters > 1 > balance Sheet > total Current Assets

25243000

Quarters > 1 > balance Sheet > property Plant Equipment

546000

Quarters > 1 > balance Sheet > total Assets

25789000

Quarters > 1 > balance Sheet > payables

16692000

Quarters > 1 > balance Sheet > short Term Debt

11472000

Quarters > 1 > balance Sheet > long Term Debt

97469000

Quarters > 1 > balance Sheet > total Liabilities

133456000

Quarters > 1 > balance Sheet > equity

-107667000

Quarters > 1 > cash Flow > net Income

-19187000

Quarters > 1 > cash Flow > depreciation

75000

Quarters > 1 > cash Flow > change In Working Capital

2405000

Quarters > 1 > cash Flow > cash From Operations

-12575000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

137000

Quarters > 1 > cash Flow > net Change In Cash

-12438000

Quarters > 1 > ratios > PE

-2.4463853117429557

Quarters > 1 > ratios > PB

-0.1464184011814205

Quarters > 1 > ratios > ROE

17.82068786164749

Quarters > 1 > ratios > ROA

-74.39993795804412

Quarters > 1 > ratios > FCF

-12575000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-104.79166666666667

Quarters > 1 > health Score

29

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

168000

Quarters > 2 > income Statement > cost Of Revenue

14000

Quarters > 2 > income Statement > gross Profit

154000

Quarters > 2 > income Statement > operating Expenses

10253000

Quarters > 2 > income Statement > operating Income

-10099000

Quarters > 2 > income Statement > interest Expense

3993000

Quarters > 2 > income Statement > pretax Income

-7254000

Quarters > 2 > income Statement > net Income

-7254000

Quarters > 2 > income Statement > eps

-1.500620604054613

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

4834000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-3185000

Quarters > 2 > income Statement > operating Margin

-6011.309523809524

Quarters > 2 > income Statement > total Other Income Expense Net

2845000

Quarters > 2 > balance Sheet > cash

31013000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

0

Quarters > 2 > balance Sheet > inventories

642000

Quarters > 2 > balance Sheet > total Current Assets

37777000

Quarters > 2 > balance Sheet > property Plant Equipment

702000

Quarters > 2 > balance Sheet > total Assets

38566000

Quarters > 2 > balance Sheet > payables

15450000

Quarters > 2 > balance Sheet > short Term Debt

5958000

Quarters > 2 > balance Sheet > long Term Debt

99918000

Quarters > 2 > balance Sheet > total Liabilities

128738000

Quarters > 2 > balance Sheet > equity

-90172000

Quarters > 2 > cash Flow > net Income

-7254000

Quarters > 2 > cash Flow > depreciation

76000

Quarters > 2 > cash Flow > change In Working Capital

-1583000

Quarters > 2 > cash Flow > cash From Operations

-12043000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

13202000

Quarters > 2 > cash Flow > net Change In Cash

1159000

Quarters > 2 > ratios > PE

-1.500620604054613

Quarters > 2 > ratios > PB

-0.10775340460453356

Quarters > 2 > ratios > ROE

8.04462582619882

Quarters > 2 > ratios > ROA

-18.809313903438262

Quarters > 2 > ratios > FCF

-12043000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-71.68452380952381

Quarters > 2 > health Score

21

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

366000

Quarters > 3 > income Statement > cost Of Revenue

832000

Quarters > 3 > income Statement > gross Profit

-466000

Quarters > 3 > income Statement > operating Expenses

10027000

Quarters > 3 > income Statement > operating Income

-10493000

Quarters > 3 > income Statement > interest Expense

4032000

Quarters > 3 > income Statement > pretax Income

-10859000

Quarters > 3 > income Statement > net Income

-10859000

Quarters > 3 > income Statement > eps

-3.57321487331359

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

3039000

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-6750000

Quarters > 3 > income Statement > operating Margin

-2866.9398907103828

Quarters > 3 > income Statement > total Other Income Expense Net

-366000

Quarters > 3 > balance Sheet > cash

29854000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

131000

Quarters > 3 > balance Sheet > inventories

679000

Quarters > 3 > balance Sheet > total Current Assets

37394000

Quarters > 3 > balance Sheet > property Plant Equipment

857000

Quarters > 3 > balance Sheet > total Assets

38338000

Quarters > 3 > balance Sheet > payables

15990000

Quarters > 3 > balance Sheet > short Term Debt

374000

Quarters > 3 > balance Sheet > long Term Debt

102508000

Quarters > 3 > balance Sheet > total Liabilities

131439000

Quarters > 3 > balance Sheet > equity

-93101000

Quarters > 3 > cash Flow > net Income

-10859000

Quarters > 3 > cash Flow > depreciation

77000

Quarters > 3 > cash Flow > change In Working Capital

-3555000

Quarters > 3 > cash Flow > cash From Operations

-14809000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

4276000

Quarters > 3 > cash Flow > net Change In Cash

-10533000

Quarters > 3 > ratios > PE

-3.57321487331359

Quarters > 3 > ratios > PB

-0.06561035864276431

Quarters > 3 > ratios > ROE

11.66367708187882

Quarters > 3 > ratios > ROA

-28.324377901820647

Quarters > 3 > ratios > FCF

-14809000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-40.46174863387978

Quarters > 3 > health Score

23

Valuation > metrics > PE

-2.1774443505212737

Valuation > metrics > PB

-0.32089834568539904

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

34.76309900021368

Profitability > metrics > ROA

-69.61466567574263

Profitability > metrics > Net Margin

-315.4183673469388

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-3.1849988566201692

Risk > final Score

17

Risk > verdict

High

Liquidity > metrics > Current Ratio

1.3350270595309681

Liquidity > metrics > Quick Ratio

1.3212266987372219

Liquidity > final Score

83

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

36

Prev Profitabilities > 1

16

Prev Profitabilities > 2

23

Prev Risks > 0

15

Prev Risks > 1

20

Prev Risks > 2

20

Prev Liquidities > 0

54

Prev Liquidities > 1

94

Prev Liquidities > 2

100

Updated At

2025-12-14T00:18:08.771Z